Japan’s biggest pharmaceutical firm Takeda has announced the completion of construction of its new global headquarters in the country’s capital of Tokyo, named inventively as “Takeda Global Headquarters”.

Heron Therapeutics has been buoyed by the news that its painkiller agent HTX-011 met all of its primary and secondary endpoints in Phase 3 studies investigating its efficacy in relieving pain and opioid use in patients...

Regeneron has confirmed that its vascular endothelial growth factor (VEGF) inhibitor injection Eylea (aflibercept) met its primary endpoint in a recent Phase 3 study, showing strong results in the treatment of...

Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, announced that Novartis’ generics division in Canada, Sandoz Canada, had signed a...

Roche’ Tecentriq needs a big result in the immunotherapy space – it initially burst onto the scene as a third-to-market treatment and started gaining patients in the bladder cancer area before its rivals had managed to...

President Trump wil geld beschikbaar stellen voor onderzoek naar een vaccin tegen medicijnverslaving. Nu komen in de VS jaarlijks tienduizenden mensen om door een overdosis extreem sterke pijnstillers. In een toespraak...

UK drugs watchdog NICE has published its finance guidance recommending the use of MSD’s Keytruda (pembrolizumab) on the NHS through the Cancer Drugs Fund for the treatment of locally advanced or metastatic urothelial...

 Is de online/offline-combinatie succesvol? Omnichannel-marketing is voor veel organisaties een steeds belangrijker speerpunt om klanten te binden. Hoe staat het met belangrijke nieuwe ontwikkelingen (zoals Google Store...

De komst van het Europees Geneesmiddelenbureau (EMA) kan Nederland nagenoeg zeker niet meer ontglippen. Het Europees Parlement heeft de verhuizing van Londen naar Amsterdam goedgekeurd, op voorwaarde dat de autoriteiten...

By most measures Allergan has not had the most successful of years and one measure, in particular, is usually indicative of a company’s performance, share price. In this case, Allergan’s shares have been on a steady...

Recent data has shown that England is, on average, slower than Germany, France, Spain and Italy in making orphan medicinal products available to patients. Joe Wiley, CEO of Amryt Pharma, discusses the need to ensure...

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it has filed for bankruptcy.

Vandaag is het Nationale Diabetes Dag, een tweejaarlijks georganiseerde dag in de zorgsector die volledig in het teken staat van diabetes mellitus.

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due to personal reasons, it has emerged. Furthermore, it has been announced that current Global Head of the...

Skin specialist biopharma firm Dermira has seen its stock crash and burn following the announcement that it plans to terminate development of acne treatment olumacostat glasaretil after it failed to show statistically...

Bristol-Myers Squibb Co said on Tuesday the U.S. Food and Drug Administration had approved a new dosing schedule for its drug, Opdivo, across a number of cancers the drug is already approved to treat.

Sanofi has announced it is to team up with biotech drug discovery specialist EvoTec to leverage a new open innovation platform in the research and development of new treatments for infectious diseases.
 

Ontruzant, the biosimilar version of Herceptin (trastuzumab) originally developed by Korean firm Samsung Bioepis, has launched for patients in the UK, becoming the first biologic copycat version of Roche’s blockbuster...